News

Morgan Stanley Assumes Coverage of Recursion Pharmaceuticals (RXRX) Stock with an Equal Weight Rating
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. Morgan Stanley assumed coverage of the company’s stock with an “Equal ...
Recursion Pharmaceuticals (RXRX) Rallies 8.7% on Hypophosphatasia
Recursion Pharmaceuticals bounced back by 8.72 percent on Tuesday to close at $5.36 apiece following news that it acquired a ...
Here's Why Shares in Recursion Pharmaceuticals Surged Today
Shares in biotech company Recursion Pharmaceuticals ( RXRX 12.07%) surged by more than 12% by 11 a.m. ET today. The move is ...
Investing23d
Recursion Pharmaceuticals stockholders elect three Class I directors
Recursion Pharmaceuticals stockholders elect three Class I directorsRecursion Pharmaceuticals , Inc. (NASDAQ: RXRX), currently trading at $5.11 after declining over 10% in the past week, announced the ...
Investing23d
Recursion Pharmaceuticals stockholders elect three Class I directors
Recursion Pharmaceuticals , Inc. (NASDAQ: RXRX), currently trading at $5.11 after declining over 10% in the past week, announced the results of its 2025 annual meeting of stockholders held on ...
Investing24d
Recursion Pharmaceuticals stockholders elect three Class I directors
Recursion Pharmaceuticals , Inc. (NASDAQ: RXRX), currently trading at $5.11 after declining over 10% in the past week, announced the results of its 2025 annual meeting of stockholders held on ...